FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891924810> ?p ?o ?g. }

• W2891924810 abstract "Leukaemic stem cell (LSC) persistence remains a major obstacle to curing chronic myeloid leukaemia (CML). The bone morphogenic protein (BMP) pathway is deregulated in CML, with altered expression and response to the BMP ligands shown to impact on LSC expansion and behaviour. In this study, we determined whether alterations in the BMP pathway gene signature had any predictive value for therapeutic response by profiling 60 CML samples at diagnosis from the UK SPIRIT2 trial and correlating the data to treatment response using the 18-month follow-up data. There was significant deregulation of several genes involved in the BMP pathway with ACV1C, INHBA, SMAD7, SNAIL1 and SMURF2 showing differential expression in relation to response. Therapeutic targeting of CML cells using BMP receptor inhibitors, in combination with tyrosine kinase inhibitor (TKI), indicate a synergistic mode of action. Furthermore, dual treatment resulted in altered cell cycle gene transcription and irreversible cell cycle arrest, along with increased apoptosis compared to single agents. Targeting CML CD34+ cells with BMP receptor inhibitors resulted in fewer cell divisions, reduced numbers of CD34+ cells and colony formation when compared to normal donor CD34+ cells, both in the presence and absence of BMP4. In an induced pluripotent stem cell (iPSC) model generated from CD34+ hematopoietic cells, we demonstrate altered cell cycle profiles and dynamics of ALK expression in CML-iPSCs in the presence and absence of BMP4 stimulation, when compared to normal iPSC. Moreover, dual targeting with TKI and BMP inhibitor prevented the self-renewal of CML-iPSC and increased meso-endodermal differentiation. These findings indicate that transformed stem cells may be more reliant on BMP signalling than normal stem cells. These changes offer a therapeutic window in CML, with intervention using BMP inhibitors in combination with TKI having the potential to target LSC self-renewal and improve long-term outcome for patients." @default.
• W2891924810 created "2018-09-27" @default.
• W2891924810 creator A5009607061 @default.
• W2891924810 creator A5010910799 @default.
• W2891924810 creator A5020420655 @default.
• W2891924810 creator A5052132124 @default.
• W2891924810 creator A5057534414 @default.
• W2891924810 creator A5067693625 @default.
• W2891924810 creator A5072637924 @default.
• W2891924810 date "2018-09-11" @default.
• W2891924810 modified "2023-10-12" @default.
• W2891924810 title "Chronic myeloid leukaemia cells require the bone morphogenic protein pathway for cell cycle progression and self-renewal" @default.
• W2891924810 cites W120597284 @default.
• W2891924810 cites W1841276786 @default.
• W2891924810 cites W1926519161 @default.
• W2891924810 cites W1966943171 @default.
• W2891924810 cites W1968747503 @default.
• W2891924810 cites W1969670678 @default.
• W2891924810 cites W1972504339 @default.
• W2891924810 cites W1978489758 @default.
• W2891924810 cites W1984706329 @default.
• W2891924810 cites W1987180287 @default.
• W2891924810 cites W1987239635 @default.
• W2891924810 cites W1992949513 @default.
• W2891924810 cites W1997793743 @default.
• W2891924810 cites W1997915808 @default.
• W2891924810 cites W1998436299 @default.
• W2891924810 cites W2005550178 @default.
• W2891924810 cites W2007873620 @default.
• W2891924810 cites W2012836529 @default.
• W2891924810 cites W2018466631 @default.
• W2891924810 cites W2024290860 @default.
• W2891924810 cites W2037837200 @default.
• W2891924810 cites W2038155245 @default.
• W2891924810 cites W2039111366 @default.
• W2891924810 cites W2041004587 @default.
• W2891924810 cites W2043332526 @default.
• W2891924810 cites W2051128936 @default.
• W2891924810 cites W2062166095 @default.
• W2891924810 cites W2062567535 @default.
• W2891924810 cites W2066148382 @default.
• W2891924810 cites W2070793750 @default.
• W2891924810 cites W2072200539 @default.
• W2891924810 cites W2072601028 @default.
• W2891924810 cites W2084537337 @default.
• W2891924810 cites W2090904720 @default.
• W2891924810 cites W2093951085 @default.
• W2891924810 cites W2095100590 @default.
• W2891924810 cites W2097281134 @default.
• W2891924810 cites W2101205238 @default.
• W2891924810 cites W2102983508 @default.
• W2891924810 cites W2103562758 @default.
• W2891924810 cites W2109159904 @default.
• W2891924810 cites W2112862229 @default.
• W2891924810 cites W2112903125 @default.
• W2891924810 cites W2125164793 @default.
• W2891924810 cites W2139548754 @default.
• W2891924810 cites W2141216110 @default.
• W2891924810 cites W2149468947 @default.
• W2891924810 cites W2152603718 @default.
• W2891924810 cites W2160193499 @default.
• W2891924810 cites W2163995184 @default.
• W2891924810 cites W2279003462 @default.
• W2891924810 cites W2298863768 @default.
• W2891924810 cites W2306746467 @default.
• W2891924810 cites W2345368403 @default.
• W2891924810 cites W2475895624 @default.
• W2891924810 cites W2528188718 @default.
• W2891924810 cites W2560023695 @default.
• W2891924810 cites W2560342075 @default.
• W2891924810 cites W2593445153 @default.
• W2891924810 cites W2594167610 @default.
• W2891924810 cites W2614253029 @default.
• W2891924810 cites W2770731101 @default.
• W2891924810 cites W4244095134 @default.
• W2891924810 doi "https://doi.org/10.1038/s41419-018-0905-2" @default.
• W2891924810 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6134087" @default.
• W2891924810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30206237" @default.
• W2891924810 hasPublicationYear "2018" @default.
• W2891924810 type Work @default.
• W2891924810 sameAs 2891924810 @default.
• W2891924810 citedByCount "11" @default.
• W2891924810 countsByYear W28919248102019 @default.
• W2891924810 countsByYear W28919248102020 @default.
• W2891924810 countsByYear W28919248102021 @default.
• W2891924810 countsByYear W28919248102022 @default.
• W2891924810 countsByYear W28919248102023 @default.
• W2891924810 crossrefType "journal-article" @default.
• W2891924810 hasAuthorship W2891924810A5009607061 @default.
• W2891924810 hasAuthorship W2891924810A5010910799 @default.
• W2891924810 hasAuthorship W2891924810A5020420655 @default.
• W2891924810 hasAuthorship W2891924810A5052132124 @default.
• W2891924810 hasAuthorship W2891924810A5057534414 @default.
• W2891924810 hasAuthorship W2891924810A5067693625 @default.
• W2891924810 hasAuthorship W2891924810A5072637924 @default.
• W2891924810 hasBestOaLocation W28919248101 @default.
• W2891924810 hasConcept C10205521 @default.
• W2891924810 hasConcept C104317684 @default.
• W2891924810 hasConcept C107459253 @default.
• W2891924810 hasConcept C109159458 @default.

• next